Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
When does Spotify Wrapped come out? The music streamer says 'soon.' - 2Family-Accommodating Snow Sports Experiences
- 3Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- 4A 'Stranger Things' documentary covering the final season is on its way: Watch the trailer
- 5US FDA declines to approve Corcept's drug for rare hormonal disorder
- Embrace Effortlessness: Moderation and Cleaning up Tips
- A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- Figure out How to Put resources into Lab Precious stones
- Indonesian Mega-Farm Drives Surge in Deforestation
- South Korea president says Iran war shows the need to ditch ‘extremely risky’ fossil fuels
- Full Supreme Court to hear challenge to Judicial Selection Committee law
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Instructions to Arrange Your Compensation During Medical caretaker Prospective employee meetings
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
